BioCentury
ARTICLE | Tools & Techniques

High throughput remyelination

August 7, 2014 7:00 AM UTC

Remyelinating compounds are highly sought after but have been difficult to identify in part because there is a dearth of high throughput screening platforms to detect remyelination. Researchers at the University of California, San Francisco have now developed an assay to visualize the process in a microtiter plate and used it to identify compounds that can promote the process.1

The screening platform has been licensed by Inception 5 Inc., a built-to-buy incubator company partnered with Roche.2...